Evidence map›Paper›PMID 38809363›Full record

ArticleJournal of nephrology2024

Donor genetic burden for cerebrovascular risk and kidney transplant outcome.

Kane E Collins, Edmund Gilbert, Vincent Mauduit, Katherine A Benson, Elhussein A E Elhassan, Conall O'Seaghdha, Claire Hill, Amy Jayne McKnight, Alexander P Maxwell, Peter J van der Most and 14 more

Abstract read
In one paragraph

Article in Journal of nephrology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Donor and Recipient Polygenic Risk Scores Influence Kidney Transplant Function.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Article
  2. Article
  3. Novel Aspects of Immunogenetics and Post-Transplant Events in Kidney Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Kane E CollinsSchool of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.ORCID 0000-0001-9839-3559
Edmund GilbertSchool of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
Vincent MauduitCenter for Research in Transplantation and Translational Immunology, UMR1064, Nantes University, Ecole Centrale Nantes, INSERM, Nantes, France.
Katherine A BensonSchool of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
Elhussein A E ElhassanDepartment of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland.
Conall O'SeaghdhaDepartment of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland.
Claire HillCentre for Public Health, Queen's University Belfast, Belfast, United Kingdom.
Amy Jayne McKnightCentre for Public Health, Queen's University Belfast, Belfast, United Kingdom.
Alexander P MaxwellCentre for Public Health, Queen's University Belfast, Belfast, United Kingdom.
Peter J van der MostDepartment of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Martin H de BorstDepartment of Internal Medicine, Divison of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Weihua GuanDivision of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
Pamala A JacobsonCollege of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.
Ajay K IsraniCollege of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.
Brendan J KeatingDepartment of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Graham M LordFaculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Salla MarkkinenFinnish Red Cross Blood Service, Research and Development, Biomedicum 1, Helsinki, Finland.
Ilkka HelanteräTransplantation and Liver Surgery, Helsinki University Hospital, Helsinki, Finland.
Kati HyvärinenFinnish Red Cross Blood Service, Research and Development, Biomedicum 1, Helsinki, Finland.
Jukka PartanenFinnish Red Cross Blood Service, Research and Development, Biomedicum 1, Helsinki, Finland.
Stephen F MaddenData Science Centre, Royal College of Surgeons in Ireland, Beaux Lane House, Dublin, Ireland.
Sophie LimouCenter for Research in Transplantation and Translational Immunology, UMR1064, Nantes University, Ecole Centrale Nantes, INSERM, Nantes, France.
Gianpiero L Cavalleri *School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
Peter J Conlon *Department of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland. peterconlon@beaumont.ie.

Funding

Atlantic Philanthropies ES/L008459/1Guy's & St Thomas' Foundation R080530Guy's & St Thomas' Foundation R090782Medical Research Council G0600698Medical Research Council G0801537/ID: 88245Medical Research Council MC_PC_20026Medical Research Council MR/J006742/1Medical Research Council MR/J006742/1; G0802068Medical Research Council MR/K002996/1Pays de la Loire region 2018-09998Science Foundation Ireland 15/IA/3152Science Foundation Ireland 18/CRT/6214Seventh Framework Programme HEALTHF5-2010-260687UK Research and Innovation MC_PC_20026Wellcome TrustWellcome Trust 076113Wellcome Trust 088849/Z/09/ZWellcome Trust 090355/A/09/ZWellcome Trust 090355/B/09/Z
6 · The paper itself

Abstract

background and hypothesisKidney grafts from donors who died of stroke and related traits have worse outcomes relative to grafts from both living donors and those who died of other causes. We hypothesise that deceased donors, particularly those who died of stroke, have elevated polygenic burden for cerebrovascular traits. We further hypothesise that this donor polygenic burden is associated with inferior graft outcomes in the recipient.

methodsUsing a dataset of 6666 deceased and living kidney donors from seven different European ancestry transplant cohorts, we investigated the role of polygenic burden for cerebrovascular traits (hypertension, stroke, and intracranial aneurysm (IA)) on donor age of death and recipient graft outcomes.

resultsWe found that kidney donors who died of stroke had elevated intracranial aneurysm and hypertension polygenic risk scores, compared to healthy controls and living donors. This burden was associated with age of death among donors who died of stroke. Increased donor polygenic risk for hypertension was associated with reduced long term graft survival (HR: 1.44, 95% CI [1.07, 1.93]) and increased burden for hypertension, and intracranial aneurysm was associated with reduced recipient estimated glomerular filtration rate (eGFR) at 1 year.

conclusionsCollectively, the results presented here demonstrate the impact of inherited factors associated with donors' death on long-term graft function.

Indexed as

Graft SurvivalHypertensionKidney TransplantationStrokeAdultAge FactorsFemaleGenetic Predisposition to DiseaseGlomerular Filtration RateHumansIntracranial AneurysmLiving DonorsMaleMiddle AgedMultifactorial InheritanceRisk AssessmentDonorsGeneticsPolygenic risk scoresPost-transplant eGFRStroke

Identifiers

PMID38809363
PMCPMC11473625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.